{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T05:18:24Z","timestamp":1726204704725},"reference-count":40,"publisher":"Oceanside Publications Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["allergy asthma proc"],"published-print":{"date-parts":[[2021,3,1]]},"abstract":"<jats:p>Cutaneous blisters and\/or bullae can occur in autoimmune disorders, infections, genetic diseases, and drug hypersensitivity. We present the case of a 62-year-old man with two autoimmune conditions who was admitted for antibiotic treatment of a lower extremity infection and suddenly developed a bullous rash. His physical examination was significant for tense, bullous lesions that involved his chin, palms, and inner thighs. Narrowing the differential diagnosis for patients with blistering skin lesions is imperative for timely and appropriate management.<\/jats:p>","DOI":"10.2500\/aap.2021.42.200055","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T04:52:24Z","timestamp":1615265544000},"page":"175-179","source":"Crossref","is-referenced-by-count":7,"title":["A 62-year-old man with new-onset bullae"],"prefix":"10.2500","volume":"42","author":[{"given":"August J.","family":"Generoso","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordana A.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan H.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1355","reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1756-0500-4-236","article-title":"The study of vancomycin use and its adverse reactions associated to patients of a Brazilian university hospital","volume":"4","author":"Marinho","year":"2011","journal-title":"BMC Res Notes"},{"key":"B2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.4168\/aair.2011.3.3.194","article-title":"Vancomycin-associated spontaneous cutaneous adverse drug reactions","volume":"3","author":"An","year":"2011","journal-title":"Allergy Asthma Immunol Res"},{"key":"B3","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2340\/00015555-3154","article-title":"Drug-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"99","author":"Lammer","year":"2019","journal-title":"Acta Derm Venereol"},{"key":"B4","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3389\/fmed.2018.00296","article-title":"Diagnosis of autoimmune blistering diseases","volume":"5","author":"Witte","year":"2018","journal-title":"Front Med (Lausanne)"},{"issue":"Pt 2","key":"B5","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S0190-9622(96)90073-0","article-title":"Vancomycin-induced linear IgA bullous dermatosis (LABD)","volume":"34","author":"Whitworth","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"B6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1046\/j.1365-2133.2001.04492.x","article-title":"Vancomycin-induced linear IgA disease with autoantibodies to bp180 and lad285","volume":"145","author":"Palmer","year":"2001","journal-title":"Br J Dermatol"},{"issue":"Pt 1","key":"B7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0190-9622(94)70015-X","article-title":"Drug-induced linear IgA bullous dermatosis: report of six cases and review of the literature","volume":"30","author":"Kuechle","year":"1994","journal-title":"J Am Acad Dermatol"},{"key":"B8","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0190-9622(88)70236-4","article-title":"Chronic bullous disease of childhood, childhood cicatricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap","volume":"19","author":"Wojnarowska","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"B9","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.anai.2017.10.007","article-title":"Linear IgA bullous dermatosis: a rare manifestation of vancomycin hypersensitivity","volume":"120","author":"Vinnakota","year":"2018","journal-title":"Ann Allergy Asthma Immunol"},{"key":"B10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/ced.13030","article-title":"Piperacillin-tazobactam\u2013induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome\/toxic epidermal necrolysis overlap","volume":"42","author":"Adler","year":"2017","journal-title":"Clin Exp Dermatol"},{"key":"B11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5021\/ad.2008.20.2.102","article-title":"Vancomycin-induced linear IgA bullous dermatosis: a case report and review of the literature","volume":"20","author":"Kang","year":"2008","journal-title":"Ann Dermatol"},{"key":"B12","first-page":"7318305","article-title":"A rare case of vancomycin-induced linear immunoglobulin a bullous dermatosis","volume":"2017","author":"Jha","year":"2017","journal-title":"Case Rep Dermatol Med"},{"key":"B13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1046\/j.1365-2230.1999.00485.x","article-title":"IgA basement membrane zone autoantibodies in bullous pemphigoid detect epidermal antigens of 270\u2013280 kDa, 230 kDa, and 180 kDa molecular weight by immunoblotting","volume":"24","author":"Kirtschig","year":"1999","journal-title":"Clin Exp Dermatol"},{"key":"B14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.clindermatol.2011.03.008","article-title":"Linear immunoglobulin A bullous dermatosis","volume":"30","author":"Fortuna","year":"2012","journal-title":"Clin Dermatol"},{"key":"B15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.ijporl.2004.02.014","article-title":"Upper aerodigestive tract complications in a neonate with linear IgA bullous dermatosis","volume":"68","author":"Gluth","year":"2004","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"B16","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.det.2011.03.013","article-title":"Linear IgA disease: clinical presentation, diagnosis, and pathogenesis","volume":"29","author":"Venning","year":"2011","journal-title":"Dermatol Clin"},{"key":"B17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2133.2006.07315.x","article-title":"Linear IgA disease presenting as prurigo nodularis","volume":"155","author":"Torchia","year":"2006","journal-title":"Br J Dermatol"},{"key":"B18","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/j.0303-6987.2004.00190.x","article-title":"Vancomycin-induced linear IgA disease manifesting as bullous erythema multiforme","volume":"31","author":"Armstrong","year":"2004","journal-title":"J Cutan Pathol"},{"key":"B19","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1111\/bjd.12488","article-title":"Linear IgA bullous dermatosis: comparison between the drug-induced and spontaneous forms","volume":"169","author":"Chanal","year":"2013","journal-title":"Br J Dermatol"},{"key":"B20","first-page":"157","article-title":"Early diagnosis is key in vancomycin-induced linear IgA bullous dermatosis and Stevens-Johnson syndrome","volume":"104","author":"Jones","year":"2004","journal-title":"J Am Osteopath Assoc"},{"key":"B21","first-page":"adv00070","article-title":"Autoantibody profile of a cohort of 54 Italian patients with linear IgA bullous dermatosis: LAD-1 denoted as a major auto-antigen of the lamina lucida subtype","volume":"100","author":"Cozzani","year":"2020","journal-title":"Acta Derm Venereol"},{"key":"B22","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0738-081X(91)90030-O","article-title":"Linear IgA bullous dermatosis of adults","volume":"9","author":"Chorzelski","year":"1991","journal-title":"Clin Dermatol"},{"key":"B23","first-page":"849","article-title":"Case reports of linear IgA bullous dermatosis of childhood","volume":"28","author":"Ang","year":"1999","journal-title":"Ann Acad Med Singapore"},{"key":"B24","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1046\/j.1365-2133.2000.03625.x","article-title":"Linear IgA disease: successful treatment with cyclosporin","volume":"143","author":"Young","year":"2000","journal-title":"Br J Dematol"},{"key":"B25","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/bjd.15244","article-title":"Idiopathic linear IgA bullous dermatosis: prognostic factors based on a case series of 72 adults","volume":"177","author":"Gottlieb","year":"2017","journal-title":"Br J Dermatol"},{"key":"B26","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.det.2011.03.022","article-title":"Clinical features, diagnosis, and pathogenesis of chronic bullous disease of childhood","volume":"29","author":"Mintz","year":"2011","journal-title":"Dermatol Clin"},{"key":"B27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0738-081X(91)90031-F","article-title":"Linear IgA bullous dermatosis of childhood (chronic bullous dermatosis of childhood)","volume":"9","author":"Jab\u0142o\u0144ska","year":"1991","journal-title":"Clin Dermatol"},{"key":"B28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D3676552R9","article-title":"Drug-induced linear IgA bullous dermatosis","volume":"12","author":"Navi","year":"2006","journal-title":"Dermatol Online J"},{"key":"B29","article-title":"Impetigo and ecthyma. Merck manual professional version","author":"Dhar","year":"2019","journal-title":"Merck"},{"key":"B30","article-title":"Bullous pemphigoid. Merck manual professional version","author":"Peraza","year":"2019","journal-title":"Merck"},{"key":"B31","article-title":"Epidermolysis bullosa acquisita. Merck manual professional version","author":"Peraza","year":"2019","journal-title":"Merck"},{"key":"B32","article-title":"Dermatitis herpetiformis. Merck manual professional version","author":"Peraza","year":"2019","journal-title":"Merck"},{"key":"B33","article-title":"(SJS) and toxic epidermal necrolysis (TEN). Merck manual professional version","author":"Gonzalez","year":"2019","journal-title":"Merck"},{"key":"B34","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jdcr.2018.07.013","article-title":"Generalized bullous fixed-drug eruption secondary to the influenza vaccine","volume":"4","author":"Byrd","year":"2018","journal-title":"JAAD Case Rep"},{"key":"B35","article-title":"Skin manifestations of internal disease. Merck manual professional version","author":"Benedetti","year":"2019","journal-title":"Merck"},{"key":"B36","article-title":"Pemphigus vulgaris. Merck manual professional version","author":"Peraza","year":"2019","journal-title":"Merck"},{"key":"B37","article-title":"Erythema multiforme. Merck manual professional version","author":"Gonzalez","year":"2019","journal-title":"Merck"},{"key":"B38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/JSM.0000000000000424","article-title":"First-aid treatment for friction blisters: \u201cwalking into the right direction?","volume":"28","author":"Janssen","year":"2018","journal-title":"Clin J Sport Med"},{"key":"B39","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4103\/0973-3930.50714","article-title":"Bullosis diabeticorum: a distinctive blistering eruption in diabetes mellitus","volume":"29","author":"Ghosh","year":"2009","journal-title":"Int J Diabetes Dev Ctries"},{"key":"B40","article-title":"Contact dermatitis. Merck manual professional version","author":"Gonzalez","year":"2019","journal-title":"Merck"}],"container-title":["Allergy and Asthma Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ingentaconnect.com\/content\/ocean\/aap\/2021\/00000042\/00000002\/art00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T19:13:09Z","timestamp":1671563589000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ingentaconnect.com\/content\/10.2500\/aap.2021.42.200055"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3,1]]}},"alternative-id":["1088-5412(20210301)42:2L.175;1-"],"URL":"https:\/\/doi.org\/10.2500\/aap.2021.42.200055","relation":{},"ISSN":["1088-5412"],"issn-type":[{"value":"1088-5412","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3,1]]}}}